Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Net Cash Provided by (Used in) Operating Activities, Continuing Operations

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Net Cash Provided by (Used in) Operating Activities, Continuing Operations

LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $63.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-02-28

  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-12-31 was $10.25M, a 14.86% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-09-30 was $3.73M.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-06-30 was $4.01M, a 42.22% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-03-31 was $2.58M, a 5.26% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $63.00M, a 50.98% increase from fiscal 2015.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $41.73M, a 102.89% increase from fiscal 2014.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $20.57M, a 3.59% decline from fiscal 2013.
  • LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was $21.33M, a 1910.56% increase from fiscal 2012.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed
2016-12-31$63.00M
10-K · filed 2017-02-28
2015-12-31$41.73M
10-K · filed 2017-02-28
2014-12-31$10.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$13.98M
derived: sum of 2 quarters · filed 2017-02-28
$17.99M
derived: sum of 3 quarters · filed 2017-02-28
$20.57M
10-K · filed 2017-02-28
$21.33M
10-K · filed 2014-12-01
2014-09-30$3.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
$7.74M
derived: sum of 2 quarters · filed 2014-10-31
$10.32M
10-Q · filed 2014-10-31
$22.35M
derived: sum of 4 quarters · filed 2016-11-14
2014-06-30$4.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$6.58M
10-Q · filed 2014-08-05
$18.62M
derived: sum of 3 quarters · filed 2016-11-14
$18.26M
derived: sum of 4 quarters · filed 2016-11-14
2014-03-31$2.58M
10-Q · filed 2014-05-07
$14.61M
derived: sum of 2 quarters · filed 2016-11-14
$14.25M
derived: sum of 3 quarters · filed 2016-11-14
$21.19M
derived: sum of 4 quarters · filed 2016-11-14
2013-12-31$12.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14
$11.68M
derived: sum of 2 quarters · filed 2016-11-14
$18.61M
derived: sum of 3 quarters · filed 2016-11-14
$21.33M
10-K · filed 2016-11-14
2013-09-30-$359.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
$6.58M
derived: sum of 2 quarters · filed 2014-10-31
$9.30M
10-Q · filed 2014-10-31
$11.82M
derived: sum of 4 quarters · filed 2015-02-23
2013-06-30$6.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05
$9.66M
10-Q · filed 2014-08-05
$12.18M
derived: sum of 3 quarters · filed 2015-02-23
$11.62M
derived: sum of 4 quarters · filed 2015-02-23
2013-03-31$2.72M
10-Q · filed 2014-05-07
$5.24M
derived: sum of 2 quarters · filed 2015-02-23
$4.68M
derived: sum of 3 quarters · filed 2015-02-23
$3.95M
derived: sum of 4 quarters · filed 2015-02-23
2012-12-31$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23
$1.96M
derived: sum of 2 quarters · filed 2015-02-23
$1.23M
derived: sum of 3 quarters · filed 2015-02-23
$1.06M
10-K · filed 2015-02-23
2012-09-30-$560.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
-$1.29M
derived: sum of 2 quarters · filed 2013-11-08
-$1.46M
10-Q · filed 2013-11-08
$5.56M
derived: sum of 4 quarters · filed 2014-12-12
2012-06-30-$732.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$901.00K
10-Q · filed 2013-08-01
$6.12M
derived: sum of 3 quarters · filed 2014-12-12
$5.06M
derived: sum of 4 quarters · filed 2014-12-12
2012-03-31-$169.00K
10-Q · filed 2013-05-08
$6.85M
derived: sum of 2 quarters · filed 2014-12-12
$5.79M
derived: sum of 3 quarters · filed 2014-12-12
-$2.25M
derived: sum of 4 quarters · filed 2014-12-12
2011-12-31$7.02M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12
$5.96M
derived: sum of 2 quarters · filed 2014-12-12
-$2.08M
derived: sum of 3 quarters · filed 2014-12-12
-$1.17M
10-K/A · filed 2014-12-12
2011-09-30-$1.05M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14
-$9.10M
derived: sum of 2 quarters · filed 2012-11-14
-$8.19M
10-Q · filed 2012-11-14
-$9.47M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30-$8.04M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-11-14
-$7.13M
10-Q/A · filed 2012-11-14
-$8.41M
derived: sum of 3 quarters · filed 2013-03-14
-$16.09M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$911.00K
10-Q/A · filed 2012-11-14
-$367.00K
derived: sum of 2 quarters · filed 2013-03-14
-$8.04M
derived: sum of 3 quarters · filed 2013-03-14
2010-12-31-$1.28M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14
-$8.95M
derived: sum of 2 quarters · filed 2013-03-14
-$27.31M
10-K · filed 2013-03-14
2010-09-30-$7.67M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-02-10
-$26.03M
10-Q/A · filed 2012-02-10
2010-06-30-$18.36M
10-Q/A · filed 2012-02-10
2009-12-31-$30.64M
10-K/A · filed 2012-11-14